Contact Person : Mark Geisler; Last Date for the submission of abstract : Not Available ; Description : Treatment of hematological malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted